FindMyKOL
Clinical trialNCT04354389WithdrawnPhase 2/PHASE3Interventional

DAS181 for STOP COVID-19

SponsorAnsun Biopharma, Inc.Enrollment0COVID-19
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

It is a multicenter, randomized, placebo-controlled, double-blind study. The study population is defined as subjects diagnosed with lower respiratory tract COVID-19 who require supplemental oxygen ≥2 LPM at the time of randomization.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico

    Milan, Italy

  • A.O.U Policlinico Di Modena

    Modena, Italy

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DAS181Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jul 2020
Primary completion
30 Sept 2020
Completion
30 Nov 2020
Last update posted
11 Aug 2020
Registered enrollment
0
Registry id
NCT04354389

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-003192-17
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.